Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System

Inclusion Criteria:

1. Healthy female and male subjects between 18 to 75 years of age with Fitzpatrick SkinType I - VI.

2. Willing to receive Profound Matrix treatments with any of the following applicators:Sublime, Sublative RF, and/or Matrix Pro applicator

3. Able and willing to comply with the treatment/follow-up schedule and comply with allstudy (protocol) requirements.

4. Willing to provide signed, informed consent to participate in the study

5. Willing to have photographs and images taken of the treated areas to be used inevaluations, publications, presentations, and marketing materials (Subject identitywill be masked).

Exclusion Criteria:

Any of the following will exclude the subject from the study:

1. Pregnant or planning to become pregnant, having given birth less than 3 months priorto enrollment into the study, and/or breast feeding

2. Pacemaker or internal defibrillator or any active electrical implant anywhere in thebody

3. Superficial metal or other implants in the treatment area, except superficial dentalimplants, unless these implants can be removed or covered with rolled gauze duringtreatment

4. Skin cancer in the treatment area or history of melanoma

5. History of current cancer and subject has undergone chemotherapy within the last 12months

6. Severe concurrent conditions, such as cardiac disorders

7. Impaired immune system or use of immunosuppressive medications

8. Herpes Simplex Virus (HSV) in the intended treatment area unless treated following aprophylactic regimen

9. Poorly controlled endocrine disorders such as poorly controlled diabetes

10. Active skin condition in the treatment area such as skin infection, sores,psoriasis, eczema, rash, or open wounds

11. History of abnormal wound healing, keloid, or hypertrophic scar formation, as wellas very thin or fragile skin

12. History of collagen vascular disease or vasculitic disorders

13. Known allergy to medication to be used during treatments such as allergy to topicalanesthetic (e.g. lidocaine)

14. History of systemic corticosteroid therapy in past six months

15. Tattoos or permanent makeup in the intended treatment area

16. Excessively tanned skin

17. Facelift in the last 12 months

18. Aesthetics treatments/procedures (e.g. facial resurfacing and deep chemical peeling)within the last 4 months within the intended treatment area

19. Neuromodulator injections (e.g. Botox®), collagen, non-permanent dermal filler, orfat injections or other methods of augmentation with injected bio-material in thetreated area within the last 3 months

20. Permanent synthetic fillers (e.g. silicone) in the treatment area

21. Absorbable facial threads within the last 1 year or non-absorbable facial threadswithin the intended treatment area

22. In the opinion of the Investigator, the subject is unwilling or unable to adhere tothe study requirements or is otherwise unsuitable for the study